ALS Clinical Trials in New York

Showing 81-99 of 99 trials

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

NCT02494024

This study will evaluate the safety and tolerability (maximum tolerated dose (MTD) within the specified dosing range) of single intravenous (IV) infusion of C2N-8E12 in patients with progressive supranuclear palsy (PSP).

Progressive Supranuclear Palsy

C2N Diagnostics32 participantsStarted Jul 2015

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +9 more locations

COMPLETEDPhase 1/2< 1 mile

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

NCT01083667

The objective of this study will be to evaluate the safety, tolerability and effect on SOD1 levels by pyrimethamine in patients with familial amyotrophic lateral sclerosis.

Familial Amyotrophic Lateral Sclerosis

Weill Medical College of Cornell University32 participantsStarted Nov 2009

New York, New York, United States • Houston, Texas, United States • Ulm, Germany +2 more locations

COMPLETEDPhase 1/2< 1 mile

Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy

NCT01537549

Studies have shown that alpha-lipoic acid and L-acetyl carnitine may have some neuroprotective activities and it is hoped that they could be helpful for people with neurodegenerative illnesses such as progressive supranuclear palsy (PSP). The purpose of this study is to find out whether the nutritional supplement alpha-lipoic acid/L-acetyl carnitine is safe and well-tolerated in individuals with PSP when given daily, and whether it affects their well-being, brain scan measurements and blood tests that measure the energy metabolism in cells.

Progressive Supranuclear Palsy

Weill Medical College of Cornell University11 participantsStarted Sep 2010

New York, New York, United States

PreviousPage 5 of 5

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy

ALS Trials in Other Cities

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Coping Effectiveness Training for ALS

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Minocycline to Treat Amyotrophic Lateral Sclerosis

The Effect of Combined Armeospring and CIT on Neuro-motor and Functional Recovery in Children With Unilateral CP

Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Novofine Autocover Safety Needle Versus BD Safety Glide

A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Study of Electrical Impedance Myography (EIM) in ALS

Other Conditions in New York